Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Effectiveness and Safety of Oral Azvudine in Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Cohort Study

NCT06349655 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.

NCT NCT06349655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06349655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Effectiveness and Safety of Oral Azvudine in Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Cohort Study
Lead sponsor
The First Affiliated Hospital of Zhengzhou University
Phase
Observational
Overall status
Completed
Start date
December 5, 2023
Completion date
March 10, 2024
Enrollment
32,864 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

azvudine, covid-19